FX5, a non-steroidal glucocorticoid receptor antagonist, ameliorates diabetic cognitive impairment in mice.
Zhu DY, Lu J, Xu R, Yang JZ, Meng XR, Ou-Yang XN, Yan QY, Nie RF, Zhao T, Chen YD, Lu Y, Zhang YN, Li WJ, Shen X.
Zhu DY, et al. Among authors: yang jz.
Acta Pharmacol Sin. 2022 Oct;43(10):2495-2510. doi: 10.1038/s41401-022-00884-9. Epub 2022 Mar 8.
Acta Pharmacol Sin. 2022.
PMID: 35260821
Free PMC article.